Literature DB >> 31673930

Comment on "Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-Analysis".

Bolin Wang1, Yan Huang2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31673930     DOI： 10.1007/s40291-019-00432-y

Source DB:  PubMed          Journal:  Mol Diagn Ther        ISSN： 1177-1062            Impact factor:   4.074


× No keyword cloud information.
  3 in total

1.  FOXC1 promotes proliferation and epithelial-mesenchymal transition in cervical carcinoma through the PI3K-AKT signal pathway.

Authors:  Liu Huang; Zheng Huang; Yi Fan; Langchi He; Ming Ye; Kun Shi; Bing Ji; Jiezhen Huang; Yibin Wang; Qiufen Li
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

Review 2.  Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-Analysis.

Authors:  Nadana Sabapathi; Shanthi Sabarimurugan; Madhav Madurantakam Royam; Chellan Kumarasamy; Xingzhi Xu; Gaixia Xu; Rama Jayaraj
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

3.  FOXC1 overexpression is a marker of poor response to anthracycline-based adjuvant chemotherapy in sporadic triple-negative breast cancer.

Authors:  Y L Xu; R Yao; J Li; Y D Zhou; F Mao; B Pan; Q Sun
Journal:  Cancer Chemother Pharmacol       Date:  2017-05-10       Impact factor: 3.333
  3 in total
  1 in total

1.  Authors' Reply to Wang and Huang: "Prognostic Significance of FOXC1 in Various Cancers: A Systematic Review and Meta-analysis".

Authors:  Rama Jayaraj; Sabapathi Nadana; Shanthi Sabarimurugan; Madhav Madurantakam Royam; Chellan Kumarasamy; Xingzhi Xu; Gaixia Xu
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.